Gatti, Alessandro
 Distribuzione geografica
Continente #
EU - Europa 455
NA - Nord America 359
AS - Asia 195
OC - Oceania 10
SA - Sud America 1
Totale 1.020
Nazione #
US - Stati Uniti d'America 353
GB - Regno Unito 170
CN - Cina 160
IT - Italia 81
IE - Irlanda 47
DE - Germania 41
SE - Svezia 38
FR - Francia 29
FI - Finlandia 26
VN - Vietnam 14
RU - Federazione Russa 12
AU - Australia 10
KR - Corea 9
CA - Canada 5
IR - Iran 4
BE - Belgio 3
UA - Ucraina 3
IN - India 2
NL - Olanda 2
RO - Romania 2
SG - Singapore 2
CH - Svizzera 1
CL - Cile 1
HK - Hong Kong 1
JP - Giappone 1
PA - Panama 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.020
Città #
Southend 154
Chandler 75
Dublin 47
Beijing 45
Ann Arbor 32
Ashburn 27
New York 23
Verona 21
Woodbridge 21
Houston 20
Jinan 17
Nanjing 14
Helsinki 12
Lawrence 11
Princeton 11
Shenyang 11
Dong Ket 10
Lancaster 10
Wilmington 10
Dearborn 9
Jacksonville 8
Seoul 8
Tianjin 8
Sydney 7
Changsha 6
Zhengzhou 6
Guangzhou 5
Haikou 5
Cagliari 4
Chengdu 4
Düsseldorf 4
Hangzhou 4
Jiaxing 4
Vancouver 4
Brussels 3
Fairfield 3
Fuzhou 3
Hebei 3
Melbourne 3
Nanchang 3
Putian 3
San Francisco 3
Sindelfingen 3
Taizhou 3
Tehran 3
Trento 3
Chongqing 2
Frankfurt am Main 2
Genova 2
Kuopio 2
Lappeenranta 2
Los Angeles 2
Luton 2
Milan 2
Ningbo 2
Norwalk 2
Parma 2
Redwood City 2
Seattle 2
Singapore 2
Sprang 2
Timisoara 2
Arco 1
Bologna 1
Camisano Vicentino 1
Cerea 1
Clearwater 1
Crotone 1
Espoo 1
Fremont 1
Henderson 1
Illasi 1
Lanzhou 1
Leawood 1
Malga Leno 1
Mehlingen 1
Messina 1
Monmouth Junction 1
Nashville 1
Panama City 1
Redmond 1
Riva 1
Tashkent 1
Thiais 1
Tokyo 1
Torino 1
Toronto 1
Washington 1
Zanjan 1
Totale 752
Nome #
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 121
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 120
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 117
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 106
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 104
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 101
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 95
Isolation, expansion and functional characterization of hPL-expanded hBM-MSC for the treatment of systemic and severe acute Graft-versus-Host Disease 93
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 88
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 52
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 43
Head–neck melanoma: Clinical, histopathological and prognostic features of an Italian multicentric study 3
Totale 1.043
Categoria #
all - tutte 2.827
article - articoli 987
book - libri 0
conference - conferenze 1.574
curatela - curatele 0
other - altro 266
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 1 3
2019/2020113 9 1 2 7 11 27 4 3 9 22 7 11
2020/2021118 16 14 5 18 9 15 3 0 4 1 17 16
2021/2022115 12 39 3 5 8 0 4 4 1 4 6 29
2022/2023238 12 29 20 33 16 71 2 15 33 2 4 1
2023/2024140 5 12 6 19 16 40 4 17 3 17 1 0
Totale 1.043